Shares of CVS Health Corporation (NYSE:CVS) have been given a consensus rating of “Buy” by the twenty-five brokerages that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and sixteen have issued a buy rating on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $89.67.

A number of analysts have recently weighed in on the company. Jefferies Group LLC set a $86.00 price target on CVS Health Corporation and gave the stock a “hold” rating in a research report on Wednesday, October 18th. SunTrust Banks, Inc. set a $85.00 price target on CVS Health Corporation and gave the stock a “buy” rating in a research report on Thursday, October 12th. Needham & Company LLC reiterated a “hold” rating on shares of CVS Health Corporation in a research report on Thursday, October 12th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $95.00 price target on shares of CVS Health Corporation in a research report on Monday, October 9th. Finally, Royal Bank Of Canada assumed coverage on CVS Health Corporation in a research report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price target on the stock.

ILLEGAL ACTIVITY NOTICE: “CVS Health Corporation (CVS) Given Average Rating of “Buy” by Brokerages” was originally published by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.watchlistnews.com/cvs-health-corporation-cvs-given-average-rating-of-buy-by-brokerages/1650205.html.

In other news, EVP Thomas M. Moriarty sold 20,547 shares of the firm’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the completion of the sale, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at approximately $3,504,758.26. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Richard J. Swift sold 2,500 shares of the firm’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total value of $199,050.00. Following the sale, the director now directly owns 3,258 shares of the company’s stock, valued at $259,401.96. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 716,625 shares of company stock valued at $58,318,431. 0.61% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in CVS. FMR LLC boosted its stake in shares of CVS Health Corporation by 22.0% during the 2nd quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock worth $2,425,920,000 after acquiring an additional 5,446,930 shares in the last quarter. Boston Partners boosted its stake in shares of CVS Health Corporation by 69.1% during the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock worth $519,711,000 after acquiring an additional 2,638,888 shares in the last quarter. Parametric Portfolio Associates LLC boosted its stake in shares of CVS Health Corporation by 71.5% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock worth $317,805,000 after acquiring an additional 1,647,168 shares in the last quarter. LSV Asset Management boosted its stake in shares of CVS Health Corporation by 44.2% during the 1st quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock worth $359,523,000 after acquiring an additional 1,404,384 shares in the last quarter. Finally, Prudential Financial Inc. boosted its stake in shares of CVS Health Corporation by 61.8% during the 2nd quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock worth $237,078,000 after acquiring an additional 1,125,400 shares in the last quarter. 81.46% of the stock is owned by institutional investors and hedge funds.

Shares of CVS Health Corporation (NYSE:CVS) traded down 0.11% on Wednesday, hitting $75.91. The company’s stock had a trading volume of 7,487,069 shares. The company has a 50 day moving average of $78.80 and a 200 day moving average of $78.72. The firm has a market cap of $77.17 billion, a PE ratio of 15.12 and a beta of 0.92. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $88.21.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.02. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The business’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.32 EPS. Equities analysts forecast that CVS Health Corporation will post $5.88 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.63%. The ex-dividend date is Monday, October 23rd. CVS Health Corporation’s payout ratio is currently 39.92%.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Analyst Recommendations for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.